跳到正文
原文
Medical Xpress·· 28 天前精选AI 评分62

Karolinska研究所与UCL研究发现:严重精神疾病患者启用抗精神病药物后体重与HbA1c呈快速增加

Study finds patients experienced rapid weight gain after starting antipsychotic medication

AI 导读

英国Karolinska研究所和伦敦大学学院(UCL)在The Lancet Psychiatry发表了一项基于近9.7万名严重精神疾病患者电子健康记录的研究。

推荐理由

该研究基于近10万份电子健康记录,揭示了抗精神病药物起始后三个月内体重与HbA1c的快速变化及药物间差异。

正文 · 原文
Study finds patients experienced rapid weight gain after starting antipsychotic medication
Changes in HbA1c (A) and weight (B) before and after first antipsychotic initiation stratified by drug. Credit: The Lancet Psychiatry (2026). DOI: 10.1016/s2215-0366(26)00274-9

People with severe mental illness experienced more rapid increases in both weight and long-term blood sugar levels during the first three months after starting treatment with antipsychotic medication, according to a study from Karolinska Institutet and University College London published in The Lancet Psychiatry.

The researchers analyzed electronic health records from nearly 97,000 people in England aged between 18 and 59 with severe mental illness. The aim was to investigate how weight and HbA1c, a blood test that reflects average blood sugar levels over time, changed before and after treatment with second-generation antipsychotic medication was initiated.

During the first 90 days after treatment began, HbA1c increased by an average of 0.12 mmol/mol per week and weight by 0.21 kilograms (0.46 pounds) per week. Before treatment, the corresponding increases were 0.01 mmol/mol and 0.02 kilograms (0.04 pounds) per week, respectively.

After the first three months, the rate of change slowed. From day 91 and up to two years, HbA1c again increased by 0.01 mmol/mol per week, while weight increased by 0.03 kilograms (0.07 pounds) per week.

The study is based entirely on health record data and shows how the values changed around the start of treatment, rather than reporting results from a randomized treatment study. In addition, only around a quarter of the participants had at least one recorded HbA1c measurement and just over three-quarters had at least one weight measurement.

Early follow-up may be important

"The results show that the greatest changes occur early after treatment is initiated. This suggests that both weight and HbA1c need to be monitored from the start of treatment and during the first three months, alongside what is clinically appropriate for each patient," says Magnus Boman, professor at the Department of Medicine, Solna, Karolinska Institutet, and one of the authors of the study.

The changes differed between medications. The largest increases were seen with olanzapine treatment. Quetiapine, by contrast, was associated with weight gain but only a small change in HbA1c. The increases were generally greater among women.

People who already had prediabetes when treatment began also had a higher risk of developing type 2 diabetes. The estimated proportion who developed the disease within two years was 19% in this group, compared with 3% among people who had normal HbA1c levels at the outset.

Publication details

Juan Carlos Bazo-Alvarez et al., Change in HbA1c and weight after initiation of antipsychotic treatment in people with severe mental illness in England: an individual-level interrupted time-series analysis, The Lancet Psychiatry (2026). DOI: 10.1016/s2215-0366(26)00274-9

Journal information: The Lancet Psychiatry

Who's behind this story?

Lisa Lock

Lisa Lock

BA art history, MA material culture. Former museum editor, paramedic, and transplant coordinator. Editing for Science X since 2021. Full profile →

Andrew Zinin

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Study finds patients experienced rapid weight gain after starting antipsychotic medication (2026, October 23) retrieved 23 October 2026 from https://medicalxpress.com/news/2026-10-patients-experienced-rapid-weight-gain.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com